Annoviant Inc.

About Annoviant Inc.

Annoviant is a healthcare innovation company dedicated to developing medical devices that transform and save lives worldwide. They focus on cardiovascular applications with breakthrough technology that improves soft tissue healing.

Products & Services

TxGuard™:A patented, regenerative tissue innovation that heals and grows with the patient, addressing clinical challenges like calcification, thrombosis, and infection in biological prosthetic heart valves. It is used in cardiovascular, urology, gastro, graft, and wound applications.

TxGuard™ Cardio:A specific application of TxGuard™ for cardiovascular diseases, aimed at eliminating the need for multiple re-interventions.

TxGuard™ Pediatric:A variant of TxGuard™ designed for pediatric heart disease, including pulmonary-valved conduits.

Specialties

Regenerative tissue technology Cardiovascular applications Soft tissue healing Pediatric heart disease solutions Thrombo-resistant and calcification-resistant materials

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Phase 2b Grant T: - FT: SBIR Phase 2b Grant	A: 2990000 MR: - FA: $2.99 million FAN: 2990000	D: 2024-04-16 FD: 2024-04-16	1 investors

SBIR Phase 2b Grant Latest

2024-04-16

$3.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Ajay Houde

CEO & Co-founder

LinkedIn (Pro only)

P

Pramod Sathe

Accounting & Finance Officer

LinkedIn (Pro only)

J

Jeremy Ollerenshaw

Pre-clinical Director

N

Naren Vyavahare

CTO & Co-founder

D

Dipasha Sinha

Research Associate

L

Lisa Peacock

Regulatory Director

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Annoviant Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised